Over the past year or so, investors may have read numerous articles by emerging market (EM) equity fund managers highlighting the current low valuations in their asset class and why this makes it an attractive investment case.
It is certainly the case that EM equities currently look cheap compared to its developed counterpart on pretty much every metric, whether that is EV/EBITDA (enterprise value-to-ebitda), P/E (price-to-earnings) or P/B (price-to-book). However, this misses two important points. The first is that emerging market equities have always been cheap compared with developed markets and it would be unwise to bet against this changing overnight the next time the cycle turns. Investing in emerging markets healthcare: The main market drivers For example, a forward P/E ratio of 12 for emerging ma...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
